Tag: data integrity

Preparing for Inspector Questions on Historical Non-Compliance Cases Preparing for Inspector Questions on Historical Non-Compliance Cases The integrity and compliance of clinical trials are paramount in ensuring patient safety and the validity of data collected. With the increasing scrutiny from regulatory authorities such as the FDA, EMA, and MHRA, it is essential for clinical research…

Read More “Preparing for Inspector Questions on Historical Non-Compliance Cases” »

Tracking Trends in GCP Non-Compliance Across Programs and Portfolios Tracking Trends in GCP Non-Compliance Across Programs and Portfolios Good Clinical Practice (GCP) is essential for ensuring the integrity of clinical trials and the safety of participants. However, non-compliance with GCP guidelines is a persistent challenge across clinical research landscapes worldwide. This comprehensive tutorial aims to…

Read More “Tracking Trends in GCP Non-Compliance Across Programs and Portfolios” »

Using Non-Compliance Insights to Strengthen SOPs and Training In the landscape of clinical trials, compliance with Good Clinical Practice (GCP) is of paramount importance. Non-compliance can jeopardize the integrity of the data collected, the safety of participants, and the study’s overall success. As such, understanding non-compliance, identifying its causes, and implementing measures to prevent it…

Read More “Using Non-Compliance Insights to Strengthen SOPs and Training” »

Case Studies: GCP Non-Compliance That Led to Warning Letters Case Studies: GCP Non-Compliance That Led to Warning Letters In the highly regulated field of clinical research, adherence to Good Clinical Practice (GCP) is crucial to ensure the integrity of data and the safety of participants. This tutorial outlines notable case studies of non-compliance with GCP…

Read More “Case Studies: GCP Non-Compliance That Led to Warning Letters” »

Managing Non-Compliance in Vendor, CRO and Partner Activities Managing Non-Compliance in Vendor, CRO and Partner Activities Clinical trials are essential in bringing new therapies to market, and adherence to Good Clinical Practice (GCP) is crucial for the integrity of the research. Non-compliance can arise from various sources, including vendors, Contract Research Organizations (CROs), and other…

Read More “Managing Non-Compliance in Vendor, CRO and Partner Activities” »

Deciding When to Suspend or Terminate Sites for Persistent Issues Deciding When to Suspend or Terminate Sites for Persistent Issues In the realm of clinical trials, ensuring compliance with Good Clinical Practice (GCP) guidelines is crucial for the integrity of the research process and the safety of participants. However, there may be occasions when a…

Read More “Deciding When to Suspend or Terminate Sites for Persistent Issues” »

Linking GCP Non-Compliance to Risk Assessments and Monitoring Plans Linking GCP Non-Compliance to Risk Assessments and Monitoring Plans Good Clinical Practice (GCP) is a fundamental aspect of clinical research and is essential for maintaining the integrity of clinical trials. The regulatory frameworks established by organizations such as the FDA, EMA, and MHRA emphasize the importance…

Read More “Linking GCP Non-Compliance to Risk Assessments and Monitoring Plans” »

Re-Training, Process Changes and System Fixes as Remediation Tools Re-Training, Process Changes and System Fixes as Remediation Tools Ensuring compliance with Good Clinical Practice (GCP) is fundamental in the execution of clinical trials, especially in environments striving for excellence in real-time clinical trials. This article serves as a step-by-step guide for clinical operations, regulatory affairs,…

Read More “Re-Training, Process Changes and System Fixes as Remediation Tools” »